Top 10 Stock Picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we discuss the top 10 stock picks of Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Centessa Pharmaceuticals Plc (CNTA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 8,774,570 | $69,845,577 | -4% | 1.74% |
| 2. | EcoR1 Capital Oleg Nodelman | 5,618,779 | $44,725,481 | 1.16% | |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 2,896,128 | $23,053,179 | +3% | 0.04% |
| 4. | Octagon Capital Advisors Ting Jia | 2,060,100 | $16,398,396 | +334% | 2.62% |
| 5. | Point72 Asset Management Steve Cohen | 1,840,482 | $14,650,237 | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.63 | 10,000 | Officer, Director | 38,000 | 2022-06-24 | Filing | |
| $9.74 | 5,000 | Officer, Director | 28,000 | 2022-02-02 | Filing | |
| $9.05 | 27,500 | Officer | 27,500 | 2022-01-28 | Filing | |
| $12.82 | 796 | Director | 93,526 | 2021-12-02 | Filing | |
| $12.82 | 33,530 | Director | 3,936,970 | 2021-12-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.21 | 21,165 | Officer | 71,525 | 2024-03-25 | Filing | |
| $11.66 | 29,995 | Officer | 92,690 | 2024-03-25 | Filing | |
| $8.10 | 4,267 | Officer | 62,625 | 2024-02-01 | Filing | |
| $6.29 | 37,484 | Officer | 33,500 | 2023-09-20 | Filing | |
| $4.45 | 6,500 | Officer | 783,066 | 2023-06-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 19,963,157 | $158,906,730 | 53.64% | |
| 2. | 9,681,818 | $77,067,271 | 1.1% | |
| 3. | 3,931,818 | $31,297,271 | 37.25% | |
| 4. | 2,787,194 | $22,186,064 | 0% | |
| 5. | 2,040,816 | $16,244,895 | 1.8% |
News See All
15 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs' Samsara BioCapital
In this article, we will discuss 15 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Billionaire Hedge Funds
